Opinion|Videos|January 17, 2025
Practice Pearls for Managing Patients With Prurigo Nodularis
Author(s)Shawn Kwatra, MD, FAAD
A panelist discusses how the advent of targeted systemic therapies such as dupilumab and nemolizumab has transformed the treatment landscape for prurigo nodularis, offering more effective options for breaking the itch-scratch cycle while maintaining favorable safety profiles compared with traditional systemic treatments.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Based on our discussion today, what key insights or new perspectives could you share regarding treatment considerations for systemic therapies for prurigo nodularis?
- What take-home messages or practice pearls do you have for clinicians treating patients with prurigo nodularis?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement